Aims and scope

The journal Investigación en Discapacidad invites the interested scientific community that is involved in areas related with the study of the pathological basis, prevention, diagnosis and treatment of disability, as well as all those fields related to disabling diseases, to submit their scientific manuscripts. Investigación en Discapacidad publishes peer-reviewed biomedical and clinical reports on trends and important developments in the study of the disabilities. The journal publishes three regular issues per year and one supplemental issue.

As stated in the World Health Organization`'s International Classification of Functioning, Disability and Health, "a person's functioning and disability is conceived as a dynamic interaction between health conditions (diseases, disorders, injuries, traumas, etc.) and contextual factors. [...] Contextual Factors include both personal and environmental factors. [...] Environmental factors interact with all the components of functioning and disability. The basic construct of the Environmental Factors component is the facilitating or hindering impact of features of the physical, social and attitudinal world". This concept applies to every medical field.

The journal strives to provide its readers with a variety of innovative and relevant topics including: description of the molecular basis of various disabling pathologies through experimental models, methods diagnosis and population studies, genetic and genomic studies, functional evaluation and intervention studies, clinical studies in various groups of patients, methodology in physical medicine, orthopedics and rehabilitation, epidemiological studies in disabling conditions, technological and computational methods in the development of areas of study in mechatronics and biomedical engineering, as well as reports on vocational and sociomedical aspects of rehabilitation.

This international journal provides researchers and physicians with authoritative information on the therapeutic use of physical, behavioral and pharmaceutical agents to provide comprehensive care for people with disabilities.